Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom

Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.

Watts R, Al-Taiar A, Mooney J, Scott D, MacGregor A. The epidemiology of Takayasu arteritis in the UK. Rheumatology. 2009;48:1008–11.

Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu arteritis in India. Int J Cardiol. 1996;54:S111–6.

Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis: a study of 32 North American patients. Medicine. 1985;64:89–99.

Singh N, Hughes M, Sebire N, Brogan P. Takayasu arteritis in infancy. Rheumatology. 2013;52:2093–5.

Morales E, Pineda C, Martínez-Lavin M. Takayasu’s arteritis in children. J Rheumatol. 1991;18:1081–4.

Cakar N, Yalcinkaya F, Duzova A, Caliskan S, Sirin A, Oner A, et al. Takayasu arteritis in children. J Rheumatol. 2008;35:913–9.

Watson L, Brogan P, Peart I, Landes C, Barnes N, Cleary G. Diagnosis and assessment of disease activity in Takayasu arteritis: a childhood case illustrating the challenge. Case Rep Rheumatol. 2014;2014:603171.

Morishita KA, Rosendahl K, Brogan PA. Familial Takayasu arteritis - a pediatric case and a review of the literature. Pediatr Rheumatol Online J. 2011;9:6.

Mavrogeni S, Dimitroulas T, Chatziioannou SN, Kitas G. The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum. 2013;42:401–12.

Aluquin VPR, Albano SA, Chan F, Sandborg C, Pitlick PT. Magnetic resonance imaging in the diagnosis and follow up of Takayasu’s arteritis in children. Ann Rheum Dis. 2002;61:526–9.

Webb M, Chambers A, Al-Nahhas A, Mason JC, Maudlin L, Rahman L, et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004;31:627–34.

Unizony S, Stone JH, Stone JR. New treatment strategies in large-vessel vasculitis. Curr Opin Rheumatol. 2013;25:3–9.

Jain S, Sharma N, Singh S, Bali HK, Kumar L, Sharma BK. Takayasu arteritis in children and young Indians. Int J Cardiol. 2000;75:S153–7.

Özen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69:798–806.

Dolezalova P, Price-Kuehne FE, Özen S, Benseler SM, Cabral DA, Anton J, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis. 2013;72:1628–33.

Aydin SZ, Yilmaz N, Akar S, Aksu K, Kamali S, Yucel E, et al. Assessment of disease activity and progression in Takayasu’s arteritis with Disease Extent Index-Takayasu. Rheumatology. 2010;49:1889–93.

Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology. 2013;52:1795–801.

Dolezalova P, Wilkinson N, Brogan PA, Anton J, Benseler SM, Brunner J, et al. Paediatric Vasculitis Damage Index: a new tool for standardised disease assessment [SAT0286]. Ann Rheum Dis. 2014;73 Suppl 2:696–7. doi:10.1136/annrheumdis-2014-eular.5893.

Pan H, Cole TJ. LMSgrowth [Microsoft Excel add-in to access growth references based on the LMS method]. Version 2.76. Harlow Healthcare, Tyne & Wear, UK. 2011. http://www.healthforallchildren.com/lmsgrowth-download/ . Accessed 5 Mar 2015.

Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F. Clinical manifestations of Takayasu arteritis in India and Japan new classification of angiographic findings. Angiology. 1997;48:369–79.

Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels. 1992;7:11–7.

Virmani R, Burke AP. Pathologic features of aortitis. Cardiovasc Pathol. 1994;3:205–16.

Tombetti E, Di Chio M, Sartorelli S, Papa M, Salerno A, Bottazzi B, et al. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther. 2014;16:479.

Bravo Mancheño B, Perin F, del Mar Rodríguez Vázquez del Rey M, García Sánchez A, Alcázar Romero PP. Successful tocilizumab treatment in a child with refractory Takayasu arteritis. Pediatrics. 2012;130:e1720–4.

Unizony S, Arias-Urdaneta L, Miloslavsky E, Arvikar S, Khosroshahi A, Keroack B, et al. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res (Hoboken). 2012;64:1720–9.

Salvarani C, Magnani L, Catanoso M, Pipitone N, Versari A, Dardani L, et al. Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology. 2012;51:151–6.

Hampson LV, Whitehead J, Eleftheriou D, Brogan P. Bayesian methods for the design and interpretation of clinical trials in very rare diseases. Stat Med. 2014;33:4186–201.